Table 4.
MetaCyc ID | Pathway | ẞ Coef. | Std. err. | p-value | FDR |
---|---|---|---|---|---|
PWY-6471 | Peptidoglycan biosynthesis IV | 0.2325 | 0.0642 | 0.0003 | 0.0064 |
PWY-6749 | CMP-legionaminate biosynthesis I | 0.2955 | 0.0825 | 0.0004 | 0.0071 |
CENTFERM-PWY | Pyruvate fermentation to butanoate | 0.4072 | 0.1200 | 0.0007 | 0.0109 |
PWY-6590 | Superpathway of Clostridium acetobutylicum acidogenic fermentation | 0.4172 | 0.1229 | 0.0007 | 0.0109 |
PWY490–3 | Nitrate reduction_VI | 0.2145 | 0.0716 | 0.0029 | 0.0338 |
PWY-7456 | β-(1,4)-mannan degradation | 0.2406 | 0.0823 | 0.0036 | 0.0409 |
PWY-5177 | glutaryl-CoA degradation | 0.3461 | 0.1187 | 0.0037 | 0.0415 |
Associations tested with generalized linear models. Recruiting center (Alicante, Barcelona, Reus, Valencia), smoking status (former smoker, never smoked, smoker), diabetes status, sex, age categories (below the median, < 65 years old; above the median, > 65 years old), and intervention group (CG, IG) set as fixed effect; participant ID set as random effect. Multiple testing correction performed with the Benjamini-Hochberg procedure and features with FDR < 0.1 reported (Reference: Tertile 1).